Search
InMed Pharmaceuticals Inc
INMAdd to Watchlist
1.490USD
0.0000.00%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
4.94MMarket Cap
LossP/E TTM
Financial Health
Currency: USD Updated: 2026-06-18 The current financial score of InMed Pharmaceuticals Inc is 7.02, ranking 164 out of 389 in the Biotechnology & Medical Research industry. Its financial status is robust, and its operating efficiency is low.
Financials
9.44
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.99
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
5.18
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
5.44
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
7.08
Free cash flow
Relevant data have not been disclosed by the company yet.
